Global and China Chronic Obstructive Pulmonary Disease Drugs Market Insights, Forecast to 2027

Global and China Chronic Obstructive Pulmonary Disease Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Chronic Obstructive Pulmonary Disease Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Chronic Obstructive Pulmonary Disease Drugs Market Size Growth Rate by Type
1.2.2 Inhalers
1.2.3 Nebulizers
1.3 Market by Application
1.3.1 Global Chronic Obstructive Pulmonary Disease Drugs Market Size Growth Rate by Application
1.3.2 Emphysema
1.3.3 Chronic Bronchitis
1.3.4 Refractory Asthma
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Chronic Obstructive Pulmonary Disease Drugs Market Size, Estimates and Forecasts
2.1.1 Global Chronic Obstructive Pulmonary Disease Drugs Revenue 2016-2027
2.1.2 Global Chronic Obstructive Pulmonary Disease Drugs Sales 2016-2027
2.2 Global Chronic Obstructive Pulmonary Disease Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Chronic Obstructive Pulmonary Disease Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Chronic Obstructive Pulmonary Disease Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Chronic Obstructive Pulmonary Disease Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Chronic Obstructive Pulmonary Disease Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Chronic Obstructive Pulmonary Disease Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue Forecast by Region (2022-2027)
3 Global Chronic Obstructive Pulmonary Disease Drugs Competitor Landscape by Players
3.1 Global Top Chronic Obstructive Pulmonary Disease Drugs Manufacturers by Sales
3.1.1 Global Chronic Obstructive Pulmonary Disease Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Chronic Obstructive Pulmonary Disease Drugs Manufacturers by Revenue
3.2.1 Key Chronic Obstructive Pulmonary Disease Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Chronic Obstructive Pulmonary Disease Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Chronic Obstructive Pulmonary Disease Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Chronic Obstructive Pulmonary Disease Drugs Revenue in 2020
3.2.6 Global Chronic Obstructive Pulmonary Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Chronic Obstructive Pulmonary Disease Drugs Price by Manufacturers
3.4 Global Chronic Obstructive Pulmonary Disease Drugs Manufacturing Base Distribution, Product Types
3.4.1 Chronic Obstructive Pulmonary Disease Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chronic Obstructive Pulmonary Disease Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Chronic Obstructive Pulmonary Disease Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Chronic Obstructive Pulmonary Disease Drugs Market Size by Type (2016-2021)
4.1.1 Global Chronic Obstructive Pulmonary Disease Drugs Sales by Type (2016-2021)
4.1.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue by Type (2016-2021)
4.1.3 Chronic Obstructive Pulmonary Disease Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Chronic Obstructive Pulmonary Disease Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Chronic Obstructive Pulmonary Disease Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Chronic Obstructive Pulmonary Disease Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Chronic Obstructive Pulmonary Disease Drugs Market Size by Application (2016-2021)
5.1.1 Global Chronic Obstructive Pulmonary Disease Drugs Sales by Application (2016-2021)
5.1.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue by Application (2016-2021)
5.1.3 Chronic Obstructive Pulmonary Disease Drugs Price by Application (2016-2021)
5.2 Chronic Obstructive Pulmonary Disease Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Chronic Obstructive Pulmonary Disease Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Chronic Obstructive Pulmonary Disease Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Chronic Obstructive Pulmonary Disease Drugs Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Chronic Obstructive Pulmonary Disease Drugs Market Size YoY Growth 2016-2027
6.1.1 China Chronic Obstructive Pulmonary Disease Drugs Sales YoY Growth 2016-2027
6.1.2 China Chronic Obstructive Pulmonary Disease Drugs Revenue YoY Growth 2016-2027
6.1.3 China Chronic Obstructive Pulmonary Disease Drugs Market Share in Global Market 2016-2027
6.2 China Chronic Obstructive Pulmonary Disease Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Chronic Obstructive Pulmonary Disease Drugs Players by Sales (2016-2021)
6.2.2 China Top Chronic Obstructive Pulmonary Disease Drugs Players by Revenue (2016-2021)
6.3 China Chronic Obstructive Pulmonary Disease Drugs Historic Market Review by Type (2016-2021)
6.3.1 China Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Type (2016-2021)
6.3.2 China Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Type (2016-2021)
6.3.3 China Chronic Obstructive Pulmonary Disease Drugs Price by Type (2016-2021)
6.4 China Chronic Obstructive Pulmonary Disease Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Chronic Obstructive Pulmonary Disease Drugs Sales Forecast by Type (2022-2027)
6.4.2 China Chronic Obstructive Pulmonary Disease Drugs Revenue Forecast by Type (2022-2027)
6.4.3 China Chronic Obstructive Pulmonary Disease Drugs Price Forecast by Type (2022-2027)
6.5 China Chronic Obstructive Pulmonary Disease Drugs Historic Market Review by Application (2016-2021)
6.5.1 China Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Application (2016-2021)
6.5.2 China Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Application (2016-2021)
6.5.3 China Chronic Obstructive Pulmonary Disease Drugs Price by Application (2016-2021)
6.6 China Chronic Obstructive Pulmonary Disease Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Chronic Obstructive Pulmonary Disease Drugs Sales Forecast by Application (2022-2027)
6.6.2 China Chronic Obstructive Pulmonary Disease Drugs Revenue Forecast by Application (2022-2027)
6.6.3 China Chronic Obstructive Pulmonary Disease Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Chronic Obstructive Pulmonary Disease Drugs Market Size YoY Growth 2016-2027
7.2 North America Chronic Obstructive Pulmonary Disease Drugs Market Facts & Figures by Country
7.2.1 North America Chronic Obstructive Pulmonary Disease Drugs Sales by Country (2016-2021)
7.2.2 North America Chronic Obstructive Pulmonary Disease Drugs Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
7.2.5 Mexico
8 Asia Pacific
8.1 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Thailand
8.2.10 Malaysia
8.2.11 Philippines
8.2.12 Vietnam
9 Europe
9.1 Europe Chronic Obstructive Pulmonary Disease Drugs Market Size YoY Growth 2016-2027
9.2 Europe Chronic Obstructive Pulmonary Disease Drugs Market Facts & Figures by Country
9.2.1 Europe Chronic Obstructive Pulmonary Disease Drugs Sales by Country (2016-2021)
9.2.2 Europe Chronic Obstructive Pulmonary Disease Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 UK
9.2.6 Italy
10 Latin America
10.1 Latin America Chronic Obstructive Pulmonary Disease Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Chronic Obstructive Pulmonary Disease Drugs Market Facts & Figures by Country
10.2.1 Latin America Chronic Obstructive Pulmonary Disease Drugs Sales by Country (2016-2021)
10.2.2 Latin America Chronic Obstructive Pulmonary Disease Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Description and Business Overview
12.1.3 AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Products Offered
12.1.5 AstraZeneca Recent Development
12.2 Boehringer Ingelheim
12.2.1 Boehringer Ingelheim Corporation Information
12.2.2 Boehringer Ingelheim Description and Business Overview
12.2.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Products Offered
12.2.5 Boehringer Ingelheim Recent Development
12.3 GSK
12.3.1 GSK Corporation Information
12.3.2 GSK Description and Business Overview
12.3.3 GSK Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 GSK Chronic Obstructive Pulmonary Disease Drugs Products Offered
12.3.5 GSK Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Description and Business Overview
12.4.3 Novartis Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis Chronic Obstructive Pulmonary Disease Drugs Products Offered
12.4.5 Novartis Recent Development
12.5 Teva Pharmaceuticals
12.5.1 Teva Pharmaceuticals Corporation Information
12.5.2 Teva Pharmaceuticals Description and Business Overview
12.5.3 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Products Offered
12.5.5 Teva Pharmaceuticals Recent Development
12.6 Ache Laboratorios Farmaceuticos
12.6.1 Ache Laboratorios Farmaceuticos Corporation Information
12.6.2 Ache Laboratorios Farmaceuticos Description and Business Overview
12.6.3 Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease Drugs Products Offered
12.6.5 Ache Laboratorios Farmaceuticos Recent Development
12.7 Almirall
12.7.1 Almirall Corporation Information
12.7.2 Almirall Description and Business Overview
12.7.3 Almirall Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Almirall Chronic Obstructive Pulmonary Disease Drugs Products Offered
12.7.5 Almirall Recent Development
12.8 Aquinox Pharmaceuticals
12.8.1 Aquinox Pharmaceuticals Corporation Information
12.8.2 Aquinox Pharmaceuticals Description and Business Overview
12.8.3 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Products Offered
12.8.5 Aquinox Pharmaceuticals Recent Development
12.9 Ario Pharma
12.9.1 Ario Pharma Corporation Information
12.9.2 Ario Pharma Description and Business Overview
12.9.3 Ario Pharma Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Ario Pharma Chronic Obstructive Pulmonary Disease Drugs Products Offered
12.9.5 Ario Pharma Recent Development
12.10 Asmacure
12.10.1 Asmacure Corporation Information
12.10.2 Asmacure Description and Business Overview
12.10.3 Asmacure Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Asmacure Chronic Obstructive Pulmonary Disease Drugs Products Offered
12.10.5 Asmacure Recent Development
12.11 AstraZeneca
12.11.1 AstraZeneca Corporation Information
12.11.2 AstraZeneca Description and Business Overview
12.11.3 AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Products Offered
12.11.5 AstraZeneca Recent Development
12.12 BioMarck Pharmaceuticals
12.12.1 BioMarck Pharmaceuticals Corporation Information
12.12.2 BioMarck Pharmaceuticals Description and Business Overview
12.12.3 BioMarck Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 BioMarck Pharmaceuticals Products Offered
12.12.5 BioMarck Pharmaceuticals Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Chronic Obstructive Pulmonary Disease Drugs Industry Trends
13.2 Chronic Obstructive Pulmonary Disease Drugs Market Drivers
13.3 Chronic Obstructive Pulmonary Disease Drugs Market Challenges
13.4 Chronic Obstructive Pulmonary Disease Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Chronic Obstructive Pulmonary Disease Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Chronic Obstructive Pulmonary Disease Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Inhalers
Table 3. Major Manufacturers of Nebulizers
Table 4. Global Chronic Obstructive Pulmonary Disease Drugs Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Chronic Obstructive Pulmonary Disease Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Chronic Obstructive Pulmonary Disease Drugs Sales by Regions (2016-2021) & (K Units)
Table 7. Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Regions (2016-2021)
Table 8. Global Chronic Obstructive Pulmonary Disease Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Chronic Obstructive Pulmonary Disease Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Chronic Obstructive Pulmonary Disease Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Chronic Obstructive Pulmonary Disease Drugs Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Chronic Obstructive Pulmonary Disease Drugs Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Chronic Obstructive Pulmonary Disease Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 16. Chronic Obstructive Pulmonary Disease Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Chronic Obstructive Pulmonary Disease Drugs Revenue Share by Manufacturers (2016-2021)
Table 18. Global Chronic Obstructive Pulmonary Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Chronic Obstructive Pulmonary Disease Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Obstructive Pulmonary Disease Drugs as of 2020)
Table 20. Key Manufacturers Chronic Obstructive Pulmonary Disease Drugs Price (2016-2021) (USD/Unit)
Table 21. Chronic Obstructive Pulmonary Disease Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Chronic Obstructive Pulmonary Disease Drugs Product Type
Table 23. Date of International Manufacturers Enter into Chronic Obstructive Pulmonary Disease Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Chronic Obstructive Pulmonary Disease Drugs Sales by Type (2016-2021) (K Units)
Table 26. Global Chronic Obstructive Pulmonary Disease Drugs Sales Share by Type (2016-2021)
Table 27. Global Chronic Obstructive Pulmonary Disease Drugs Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Chronic Obstructive Pulmonary Disease Drugs Revenue Share by Type (2016-2021)
Table 29. Chronic Obstructive Pulmonary Disease Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 30. Global Chronic Obstructive Pulmonary Disease Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Chronic Obstructive Pulmonary Disease Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Chronic Obstructive Pulmonary Disease Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 35. Global Chronic Obstructive Pulmonary Disease Drugs Sales by Application (2016-2021) (K Units)
Table 36. Global Chronic Obstructive Pulmonary Disease Drugs Sales Share by Application (2016-2021)
Table 37. Global Chronic Obstructive Pulmonary Disease Drugs Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Chronic Obstructive Pulmonary Disease Drugs Revenue Share by Application (2016-2021)
Table 39. Chronic Obstructive Pulmonary Disease Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 40. Global Chronic Obstructive Pulmonary Disease Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Chronic Obstructive Pulmonary Disease Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Chronic Obstructive Pulmonary Disease Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 45. China Chronic Obstructive Pulmonary Disease Drugs Sales (K Units) of Key Companies (2016-2021)
Table 46. China Chronic Obstructive Pulmonary Disease Drugs Sales Share by Company (2016-2021)
Table 47. China Chronic Obstructive Pulmonary Disease Drugs Revenue (US$ Million) by Company (2016-2021)
Table 48. China Chronic Obstructive Pulmonary Disease Drugs Revenue Share by Company (2016-2021)
Table 49. China Chronic Obstructive Pulmonary Disease Drugs Sales (K Units) by Type (2016-2021)
Table 50. China Chronic Obstructive Pulmonary Disease Drugs Sales Share by Type (2016-2021)
Table 51. China Chronic Obstructive Pulmonary Disease Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Chronic Obstructive Pulmonary Disease Drugs Price (USD/Unit) by Type (2016-2021)
Table 53. China Chronic Obstructive Pulmonary Disease Drugs Sales (K Units) by Type (2022-2027)
Table 54. China Chronic Obstructive Pulmonary Disease Drugs Sales Share by Type (2022-2027)
Table 55. China Chronic Obstructive Pulmonary Disease Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Chronic Obstructive Pulmonary Disease Drugs Revenue Share by Type (2022-2027)
Table 57. China Chronic Obstructive Pulmonary Disease Drugs Price (USD/Unit) by Type (2022-2027)
Table 58. China Chronic Obstructive Pulmonary Disease Drugs Sales (K Units) by Application (2016-2021)
Table 59. China Chronic Obstructive Pulmonary Disease Drugs Sales Share by Application (2016-2021)
Table 60. China Chronic Obstructive Pulmonary Disease Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Chronic Obstructive Pulmonary Disease Drugs Price (USD/Unit) by Application (2016-2021)
Table 62. China Chronic Obstructive Pulmonary Disease Drugs Sales (K Units) by Application (2022-2027)
Table 63. China Chronic Obstructive Pulmonary Disease Drugs Sales Share by Application (2022-2027)
Table 64. China Chronic Obstructive Pulmonary Disease Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Chronic Obstructive Pulmonary Disease Drugs Revenue Share by Application (2022-2027)
Table 66. China Chronic Obstructive Pulmonary Disease Drugs Price (USD/Unit) by Application (2022-2027)
Table 67. North America Chronic Obstructive Pulmonary Disease Drugs Sales by Country (2016-2021) & (K Units)
Table 68. North America Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Country (2016-2021)
Table 69. North America Chronic Obstructive Pulmonary Disease Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Region (2016-2021)
Table 75. Europe Chronic Obstructive Pulmonary Disease Drugs Sales by Country (2016-2021) & (K Units)
Table 76. Europe Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Country (2016-2021)
Table 77. Europe Chronic Obstructive Pulmonary Disease Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Country (2016-2021)
Table 79. Latin America Chronic Obstructive Pulmonary Disease Drugs Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Chronic Obstructive Pulmonary Disease Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Country (2016-2021)
Table 87. AstraZeneca Corporation Information
Table 88. AstraZeneca Description and Business Overview
Table 89. AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 90. AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Product
Table 91. AstraZeneca Recent Development
Table 92. Boehringer Ingelheim Corporation Information
Table 93. Boehringer Ingelheim Description and Business Overview
Table 94. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 95. Boehringer Ingelheim Product
Table 96. Boehringer Ingelheim Recent Development
Table 97. GSK Corporation Information
Table 98. GSK Description and Business Overview
Table 99. GSK Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 100. GSK Product
Table 101. GSK Recent Development
Table 102. Novartis Corporation Information
Table 103. Novartis Description and Business Overview
Table 104. Novartis Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 105. Novartis Product
Table 106. Novartis Recent Development
Table 107. Teva Pharmaceuticals Corporation Information
Table 108. Teva Pharmaceuticals Description and Business Overview
Table 109. Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 110. Teva Pharmaceuticals Product
Table 111. Teva Pharmaceuticals Recent Development
Table 112. Ache Laboratorios Farmaceuticos Corporation Information
Table 113. Ache Laboratorios Farmaceuticos Description and Business Overview
Table 114. Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 115. Ache Laboratorios Farmaceuticos Product
Table 116. Ache Laboratorios Farmaceuticos Recent Development
Table 117. Almirall Corporation Information
Table 118. Almirall Description and Business Overview
Table 119. Almirall Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 120. Almirall Product
Table 121. Almirall Recent Development
Table 122. Aquinox Pharmaceuticals Corporation Information
Table 123. Aquinox Pharmaceuticals Description and Business Overview
Table 124. Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 125. Aquinox Pharmaceuticals Product
Table 126. Aquinox Pharmaceuticals Recent Development
Table 127. Ario Pharma Corporation Information
Table 128. Ario Pharma Description and Business Overview
Table 129. Ario Pharma Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 130. Ario Pharma Product
Table 131. Ario Pharma Recent Development
Table 132. Asmacure Corporation Information
Table 133. Asmacure Description and Business Overview
Table 134. Asmacure Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 135. Asmacure Product
Table 136. Asmacure Recent Development
Table 137. Astellas Pharma Corporation Information
Table 138. Astellas Pharma Description and Business Overview
Table 139. Astellas Pharma Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 140. Astellas Pharma Product
Table 141. Astellas Pharma Recent Development
Table 142. BioMarck Pharmaceuticals Corporation Information
Table 143. BioMarck Pharmaceuticals Description and Business Overview
Table 144. BioMarck Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 145. BioMarck Pharmaceuticals Product
Table 146. BioMarck Pharmaceuticals Recent Development
Table 147. Chronic Obstructive Pulmonary Disease Drugs Market Trends
Table 148. Chronic Obstructive Pulmonary Disease Drugs Market Drivers
Table 149. Chronic Obstructive Pulmonary Disease Drugs Market Challenges
Table 150. Chronic Obstructive Pulmonary Disease Drugs Market Restraints
Table 151. Chronic Obstructive Pulmonary Disease Drugs Customers List
Table 152. Chronic Obstructive Pulmonary Disease Drugs Distributors List
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Chronic Obstructive Pulmonary Disease Drugs Product Picture
Figure 2. Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Inhalers Product Picture
Figure 4. Nebulizers Product Picture
Figure 5. Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Application in 2020 & 2027
Figure 6. Emphysema
Figure 7. Chronic Bronchitis
Figure 8. Refractory Asthma
Figure 9. Others
Figure 10. Chronic Obstructive Pulmonary Disease Drugs Report Years Considered
Figure 11. Global Chronic Obstructive Pulmonary Disease Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Chronic Obstructive Pulmonary Disease Drugs Market Size 2016-2027 (US$ Million)
Figure 13. Global Chronic Obstructive Pulmonary Disease Drugs Sales 2016-2027 (K Units)
Figure 14. Global Chronic Obstructive Pulmonary Disease Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Region (2016-2021)
Figure 16. Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Region in 2020
Figure 17. Global Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Region (2016-2021)
Figure 18. Global Chronic Obstructive Pulmonary Disease Drugs Revenue Market Share by Region in 2020
Figure 19. Global Chronic Obstructive Pulmonary Disease Drugs Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Chronic Obstructive Pulmonary Disease Drugs Revenue in 2020
Figure 21. Chronic Obstructive Pulmonary Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Chronic Obstructive Pulmonary Disease Drugs Sales Market Share by Type (2016-2021)
Figure 23. Global Chronic Obstructive Pulmonary Disease Drugs Sales Mar

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs